Jammu (Jammu and Kashmir) [India], May 23 (ANI): CSIR-Indian Institute of Integrative Medicine hosted an important scientific interaction and collaborative meeting with renowned international scientist Prof Serge Mignani, marking another significant step towards advancing global partnerships in drug discovery research, a release said.
Prof Serge Mignani, former Head of Medicinal Chemistry and Scientific Director at Sanofi, met with Director Zabeer Ahmed and the research team of CSIR-Indian Institute of Integrative Medicine to discuss ongoing collaborative research initiatives in the areas of anti-tuberculosis (TB) drug discovery, oncology, inflammation, and CMS disease research.
During the interaction, Zabeer Ahmed welcomed Prof Serge Mignani to the institute and emphasised the importance of international scientific collaborations in accelerating innovative healthcare solutions and advancing translational research in critical disease areas.
ADVERTISEMENT
The meeting focused on strengthening Indo-French scientific cooperation under collaborative research programmes aimed at developing next-generation therapeutic agents against tuberculosis and other infectious diseases.
Prof Mignani is widely recognised for his outstanding contributions to medicinal chemistry and pharmaceutical research, it added.
At CSIR-IIIM Jammu, Prof. Mignani is associated with the institute’s Drug Discovery Division and is collaborating closely with leading scientists on the development of novel anti-TB agents.
He also interacted with researchers, scholars, and students, sharing valuable insights into modern drug discovery approaches, translational research, and the growing importance of industry-academia partnerships in pharmaceutical innovation.
Speaking during the interaction, Prof Mignani appreciated the scientific ecosystem and research capabilities at CSIR-IIIM Jammu and encouraged young researchers to pursue innovative and interdisciplinary research with dedication and global scientific vision.
He emphasised that the future of drug discovery lies in collaborative science, advanced technologies, and strong partnerships between research institutions and industry.
The meeting concluded with both sides expressing optimism about future collaborations and joint scientific advancements.
The visit is expected to further enhance CSIR-IIIM Jammu’s international research engagement and contribute significantly to ongoing efforts in infectious disease research and therapeutic development, it added (ANI)